| Tracy Dahlke, MD | |
|
740 S New St Ste B, Dover, DE 19904-3571 | |
| (302) 734-5050 | |
| Not Available |
| Full Name | Tracy Dahlke |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 33 Years |
| Location | 740 S New St Ste B, Dover, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699759720 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | C1-0005419 (Delaware) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | C1-0005419 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayhealth Hospital, Sussex Campus | Milford, DE | Hospital |
| Bayhealth Hospital, Kent Campus | Dover, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bayhealth Medical Center, Inc | 1658364740 | 288 |
| Ehg Gi De, P.a. | 3072911544 | 5 |
News Archive
Tests of the experimental Ebola vaccine VSV-ZEBOV in over 7500 participants in Guinea suggest that the vaccine provides high protection against the disease as early as ten days after vaccination, in adults who have potentially been exposed to the virus by coming in close contact with a recently infected person.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
A rare Patagonian rodent known as the colonial tuco-tuco fascinates biologists because it seems to defy all odds. This threatened species has so little genetic diversity that the slightest whiff of climate change or disease should have wiped it off the face of the earth long ago. Yet the hearty gopher-like creature has not only managed to survive for thousands of years in the harsh climate of the Argentine highlands, it has evolved a complex social structure that's unique among the more than 50 closely related tuco-tuco species.
Neurons are complex, highly connected cells engaged with multiple networks throughout the brain, and they exhibit a wide range of activity.
The improvement of public health services in the UK is hampered by one single, but probably the most important factor, the collapse in morale among doctors, and none of the UK's main political parties have attempted to address the issue in their election campaigns.
› Verified 4 days ago
| Entity Name | Richard F Caruso Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023000759 PECOS PAC ID: 9335127349 Enrollment ID: O20040707001333 |
News Archive
Tests of the experimental Ebola vaccine VSV-ZEBOV in over 7500 participants in Guinea suggest that the vaccine provides high protection against the disease as early as ten days after vaccination, in adults who have potentially been exposed to the virus by coming in close contact with a recently infected person.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
A rare Patagonian rodent known as the colonial tuco-tuco fascinates biologists because it seems to defy all odds. This threatened species has so little genetic diversity that the slightest whiff of climate change or disease should have wiped it off the face of the earth long ago. Yet the hearty gopher-like creature has not only managed to survive for thousands of years in the harsh climate of the Argentine highlands, it has evolved a complex social structure that's unique among the more than 50 closely related tuco-tuco species.
Neurons are complex, highly connected cells engaged with multiple networks throughout the brain, and they exhibit a wide range of activity.
The improvement of public health services in the UK is hampered by one single, but probably the most important factor, the collapse in morale among doctors, and none of the UK's main political parties have attempted to address the issue in their election campaigns.
› Verified 4 days ago
| Entity Name | Bayhealth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1609333590 PECOS PAC ID: 1658364740 Enrollment ID: O20190716000269 |
News Archive
Tests of the experimental Ebola vaccine VSV-ZEBOV in over 7500 participants in Guinea suggest that the vaccine provides high protection against the disease as early as ten days after vaccination, in adults who have potentially been exposed to the virus by coming in close contact with a recently infected person.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
A rare Patagonian rodent known as the colonial tuco-tuco fascinates biologists because it seems to defy all odds. This threatened species has so little genetic diversity that the slightest whiff of climate change or disease should have wiped it off the face of the earth long ago. Yet the hearty gopher-like creature has not only managed to survive for thousands of years in the harsh climate of the Argentine highlands, it has evolved a complex social structure that's unique among the more than 50 closely related tuco-tuco species.
Neurons are complex, highly connected cells engaged with multiple networks throughout the brain, and they exhibit a wide range of activity.
The improvement of public health services in the UK is hampered by one single, but probably the most important factor, the collapse in morale among doctors, and none of the UK's main political parties have attempted to address the issue in their election campaigns.
› Verified 4 days ago
| Entity Name | Bayhealth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1730646688 PECOS PAC ID: 1658364740 Enrollment ID: O20190722002207 |
News Archive
Tests of the experimental Ebola vaccine VSV-ZEBOV in over 7500 participants in Guinea suggest that the vaccine provides high protection against the disease as early as ten days after vaccination, in adults who have potentially been exposed to the virus by coming in close contact with a recently infected person.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
A rare Patagonian rodent known as the colonial tuco-tuco fascinates biologists because it seems to defy all odds. This threatened species has so little genetic diversity that the slightest whiff of climate change or disease should have wiped it off the face of the earth long ago. Yet the hearty gopher-like creature has not only managed to survive for thousands of years in the harsh climate of the Argentine highlands, it has evolved a complex social structure that's unique among the more than 50 closely related tuco-tuco species.
Neurons are complex, highly connected cells engaged with multiple networks throughout the brain, and they exhibit a wide range of activity.
The improvement of public health services in the UK is hampered by one single, but probably the most important factor, the collapse in morale among doctors, and none of the UK's main political parties have attempted to address the issue in their election campaigns.
› Verified 4 days ago
| Entity Name | Ehg Gi De, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801493069 PECOS PAC ID: 3072911544 Enrollment ID: O20211013003417 |
News Archive
Tests of the experimental Ebola vaccine VSV-ZEBOV in over 7500 participants in Guinea suggest that the vaccine provides high protection against the disease as early as ten days after vaccination, in adults who have potentially been exposed to the virus by coming in close contact with a recently infected person.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
A rare Patagonian rodent known as the colonial tuco-tuco fascinates biologists because it seems to defy all odds. This threatened species has so little genetic diversity that the slightest whiff of climate change or disease should have wiped it off the face of the earth long ago. Yet the hearty gopher-like creature has not only managed to survive for thousands of years in the harsh climate of the Argentine highlands, it has evolved a complex social structure that's unique among the more than 50 closely related tuco-tuco species.
Neurons are complex, highly connected cells engaged with multiple networks throughout the brain, and they exhibit a wide range of activity.
The improvement of public health services in the UK is hampered by one single, but probably the most important factor, the collapse in morale among doctors, and none of the UK's main political parties have attempted to address the issue in their election campaigns.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tracy Dahlke, MD 31333 Red Mill Dr, Lewes, DE 19958-3651 Ph: () - | Tracy Dahlke, MD 740 S New St Ste B, Dover, DE 19904-3571 Ph: (302) 734-5050 |
News Archive
Tests of the experimental Ebola vaccine VSV-ZEBOV in over 7500 participants in Guinea suggest that the vaccine provides high protection against the disease as early as ten days after vaccination, in adults who have potentially been exposed to the virus by coming in close contact with a recently infected person.
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
A rare Patagonian rodent known as the colonial tuco-tuco fascinates biologists because it seems to defy all odds. This threatened species has so little genetic diversity that the slightest whiff of climate change or disease should have wiped it off the face of the earth long ago. Yet the hearty gopher-like creature has not only managed to survive for thousands of years in the harsh climate of the Argentine highlands, it has evolved a complex social structure that's unique among the more than 50 closely related tuco-tuco species.
Neurons are complex, highly connected cells engaged with multiple networks throughout the brain, and they exhibit a wide range of activity.
The improvement of public health services in the UK is hampered by one single, but probably the most important factor, the collapse in morale among doctors, and none of the UK's main political parties have attempted to address the issue in their election campaigns.
› Verified 4 days ago
Dr. David Samuel Brenner, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-7050 Fax: 302-744-7682 | |
Mr. James Lowell Everette, Jr., M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-7050 Fax: 302-744-7682 | |
Dr. Anita Rose Sgrignoli, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-7050 Fax: 302-744-7682 | |
Tauhid H Awan, MD Pathology Medicare: Medicare Enrolled Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-674-4700 Fax: 302-744-7682 | |
Diego Morales Neira, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 740 S New St Ste B, Dover, DE 19904 Phone: 302-734-5050 Fax: 302-734-8080 | |
Shunli Zhang, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-7046 Fax: 302-744-7682 |